Investigational Drug Study for Adolescents and Adults with Fragile X Syndrome
What are we studying?
The purpose of the study is to evaluate whether an investigational drug is safe and effective for the treatment of symptoms of Fragile X Syndrome.
Who can participate?
Males and females between 16 and 50 years of age who have a diagnosis of Fragile X Syndrome
Participants need to exhibit behaviors such as being listless, isolating themselves, having fixed facial expressions or lack of emotions.
How will participants be compensated?
A small payment will be offered to offset travel expenses.
Docket # H-14789
Download a PDF flier for this study.
Investing in the future...helping kids and families.